観血的内視鏡手技と抗血小板薬休薬状況の検討

書誌事項

タイトル別名
  • A SURVEY OF THE RELATIONSHIP BETWEEN THE CESSATION PERIOD OF ANTI-PLATELET AGENTS ON THE INVASIVE ENDOSCOPIC PROCEDURE

この論文をさがす

抄録

Background : Since thromboembolic diseases have increased, the frequency of performing invasive endoscopic procedures on patients taking anti-platelet agents has been increased. We investigated the relationship between the cessation period and endoscopic complications. Method : We analyzed the answers from 81 endoscopists (25 hospitals) with more than 3 years of experience. The questions contain the cessation period of anti-platelet agents (aspirin, ticlopidine) before the invasive endoscopic procedure, and the complications of bleeding or infarction during and after the procedure.Results : Approximately 50% of endoscopists performing biopsies and more than 95% of them performing polypectomies and ESTs replied that they recommended the cessation of antiplatelet agents for 7-10 days before the procedures. Between April 2001 and March 2004, there were 7 cases of abnormal bleeding (including 2 cases of required blood transfusion) and 7 cases with thrombosis (one of them died of cerebral infarction).Conclusion : When invasive endoscopic procedures are performed on the patients taking antiplatelet agents, the sufficient considerations not only for bleeding complications but also for the risk of thrombosis are necessary.

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (19)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ